Researchers from the Berlin Institute of Health at Charité (BIH) and the Max Planck Institute for Molecular Genetics, in collaboration with international colleagues, published a paper in Nature Genetics on a method to detect evolutionary conserved enhancers that diverged so much that their DNA sequences do not match anymore. In an interview, Dr.…
Dr. med. Livius Penter, internist, and Dr. med. Jana Ihlow, pathologist, are fellows in the Clinician Scientist Program researching how allogeneic stem cell transplants and immunotherapeutic strategies can be used to treat acute myeloid leukaemia (AML). The Brigitte and Dr. Konstanze Wegener Foundation is now funding their joint project beginning…
With the support of SPARK-BIH and the BIH Biomedical Innovation Academy (BIA), the first cohorts in the project and personal funding programs of the National Strategy for Gene- and Cell-Based Therapies (GCT) have been selected. Within the project funding according to the SPARK method, 17 projects from 13 cities throughout Germany are being funded…
On the occasion of the European Month of Diversity, we are taking a stand for openness and inclusivity in science. For us, equal opportunities and diversity are more than just words- they are fundamental requirements for innovation and high- quality research.
In cooperation with the German Academic Exchange Service (DAAD), the Maison Heinrich Heine (MHH) and with the support of the German embassies, the exhibition ‘Berlin - Capital of Women Scientists’ travelled to Paris and Brussels.
Do you have an innovative idea or questions concerning IP and patents? The Idea Office is a service offered by Charité BIH Innovation, the joint technology transfer of Charité and the Berlin Institute of Health (BIH). It has been organized by Bettina Otto and Thomas Marek Wallach since 2022 and was supported as part of the project Detect & Dispatch…
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office workspaces, to support operations at the full-service BIH…
Researchers from the Berlin Institute of Health at Charité (BIH), the Center for Musculoskeletal Surgery at Charité – Universitätsmedizin Berlin, Jena University Hospital, ETH Zurich and the Max Planck Institute of Colloids and Interfaces have uncovered a novel mechanism that links the water-binding properties of the extracellular matrix (ECM) in…
At the beginning of May, the BIH Digital Health Accelerator welcomed the eighth project cohort with eleven new teams of innovators from clinical practice and research at Charité and BIH.
